The Story of Masks
Release time:
2021-07-01
6# January 10 , it was a rainy day. A man holding a little girl hurriedly came to Renshou Hall, a big pharmacy opposite the west gate of Jinhua Central Hospital. He was about to enter the door, but was stopped by the clerk at the door.
Recently, due to the repeated situation of the new coronary pneumonia epidemic, especially the emergence of imported cases and asymptomatic infections in surrounding provinces and cities, the daily epidemic prevention requirements of the health and epidemic prevention departments in public places have become stricter than in the previous period. Like pharmacies, you must register your personal information after measuring your body temperature and wear a mask before entering. The clerk stopped them because neither of them was wearing a mask.
customer is a middle-aged man dressed in ordinary clothes and wearing release shoes. Hearing the clerk's reminder, his rough face showed a trace of embarrassment. He said that he had some masks and forgot to bring them when he went out in a hurry. Otherwise, he would buy two in the store, one for each person.
This inconspicuous sentence has created a small problem for the clerk - The masks in the drugstore are all sealed and packaged, and at least there are 10 masks, which cannot be sold separately. Besides, it is simple to dismantle parts, but the rest do not meet the hygiene standards and can no longer be sold on the counter.
learned that he could only buy the whole package. Hearing the price, the man looked embarrassed and hesitated. It was raining outside the door. At that time, he was in a dilemma.
Manager Gao Suqin, who was busy at the counter, saw the scene and came out to ask. Knowing the reason, she looked at the old and young at the door of the store. She probably guessed the reason for their hesitation. She hurriedly walked to the desk, took out two masks from her bag and delivered them to the customers. Let them wear them, do a good job of temperature measurement and registration, and enter the store smoothly. The most intimate thing is that because the little girl has a small face, Gao Suqin gave her a children's mask.
Reporter's Note:
Perhaps in the eyes of many people, the story of this mask is just a trivial matter. Gao Suqin also said in an interview that this incident is too common and is not worth reporting at all. Similar incidents may have happened in every store of Jianfeng Pharmacy. Indeed, we can hear similar stories in various stores of large pharmacies: seeing that the old man is unable to move, he helps to deliver medicine to the door; in case of heavy rain, he brings an umbrella to the customer; picking up the items lost by the customer, and trying to find the owner ... These "small things " , which are very common and even taken for granted by the staff of large pharmacies. If you think about it from the customer, heart will give birth to a trace of touch.
For Jianfeng Group, Jianfeng Pharmacy is a window unit that directly deals with customers. Because it is related to the health of the people and has its particularity compared with ordinary commercial units, it is more necessary to treat customers sincerely and sincerely in daily work and provide good service in order to establish a long-term good relationship on the basis of mutual trust. Peak pharmacy over the years of word-of-mouth, it is in such a seemingly trivial matter to build up.
But from another perspective, the story of this mask can also bring us some thinking. At present, the overall pressure of the domestic epidemic has slowed down, the new confirmed cases are mainly imported from abroad, coupled with the development of good health habits for more than a year, the promotion of vaccination work, the mentality of the people has basically relaxed, it is not uncommon to forget to wear masks when going out. Moreover, due to the severe outbreak of the previous "hoarding " , many people still have masks to be "digestion " in their homes, if they want to go into the store and buy a large bag back, it is inevitable that people have some ideas. In response to this phenomenon, if the pharmacy can organize some individually packaged masks, it may be able to provide more convenience to customers who need it temporarily.
(Chen Shengmu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31